Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.855 EUR | +0.25% | +2.87% | +16.97% |
10/06 | Almirall: extension of indication in actinic keratosis | CF |
10/06 | Almirall’s Skin Disease Drug Gets US FDA Nod for Larger Treatment Area | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.97% | 220.73Cr | |
+41.96% | 63TCr | |
-7.15% | 35TCr | |
+18.77% | 33TCr | |
+8.79% | 30TCr | |
+18.02% | 25TCr | |
+1.27% | 22TCr | |
+11.95% | 22TCr | |
+3.68% | 16TCr | |
-4.38% | 16TCr |
- Stock Market
- Equities
- ALM Stock
- News Almirall, S.A.
- Transcript : Almirall, S.A., Q1 2022 Earnings Call, May 09, 2022